Company intelligence / Profile preview

HSL BioTechnologies

unspecified, Saint Catherine Parish, Jamaicahslbiotech.com ↗

Ownership: Private
Development stage: Preclinical

Overview

HSL BioTechnologies is building a large-scale, state-of-the-art biologics manufacturing facility in Jamaica to produce advanced biotherapeutic products—including vaccines, monoclonal antibodies, recombinant DNA and mRNA therapies—targeting oncological, neurological, metabolic, and infectious diseases. The company is led by an experienced team with global Tier 1 biopharma backgrounds. Clinical results are not yet available as the focus is on manufacturing capabilities rather than proprietary drug development at this stage[1][2].

Therapeutic areas: OncologyMetabolic DisordersNeurologyInfectious Diseases
Modalities: VaccineMonoclonal antibodyRecombinant DNA therapymRNA-based drugsProtein therapyBiologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on HSL BioTechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HSL BioTechnologies.

Explore the full profile